Clinical Studies and Trials
I have only included our most influential clinical studies and trials here, each of which represents a true “world-first” with respect to the use of metabolic strategies in a neurological disorder.
“Intensive Multimodal Ketogenic Metabolic Therapy in Glioblastoma: A Clinical Trial”
Neuro-Oncology Advances, 2026
The most intensive metabolic therapy program ever applied to patients with IDH-wildtype glioblastoma.
“Feasibility and Safety of a Combined Metabolic Strategy in Glioblastoma Multiforme: A Prospective Case Series”
Journal of Oncology, 2022
The first study to combine repeated, prolonged fasts with a ketogenic diet in patients with advanced cancer.
“Randomized Crossover Trial of a Modified Ketogenic Diet in Alzheimer’s Disease”
Alzheimer’s Research and Therapy, 2021
The first-ever randomized trial of a ketogenic diet in Alzheimer’s.
“Low-Fat Versus Ketogenic Diet in Parkinson’s Disease: A Pilot Randomized Controlled Trial”
Movement Disorders, 2018
The first-ever randomized trial of a ketogenic diet in Parkinson’s.